What’s going on in the world of radiopharmaceuticals? Find out here.
News & Events
Check out the latest radiopharmaceutical news
News & Press Releases
Nucleus RadioPharma Taps Former FDA Head Stephen Hahn as Chief Executive
Nucleus RadioPharma, a CDMO that specializes in the burgeoning field of radiopharmaceuticals, named former FDA Commissioner Dr. Stephen Hahn as its chief executive officer.
Read More
Former FDA head Stephen Hahn joins radiopharmaceuticals startup as CEO
Former Food and Drug Administration Commissioner Stephen Hahn is taking the top spot at a radiopharmaceuticals startup, bringing him back into the field where he started his career. Hahn has…
Read More
Nucleus RadioPharma Appoints Former FDA Commissioner Dr. Stephen Hahn as CEO to Scale Patient Access to Radiopharmaceutical Therapies
Nucleus RadioPharma, a next-generation contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, today announced the appointment of Dr. Stephen M. Hahn as chief executive officer. Hahn’s leadership signals Nucleus…
Read More
A New Theranostic System Designed for Radiopharma’s Real-World Demands
Nucleus RadioPharma may be known as a CDMO, but its ambitions go far beyond manufacturing. With control over both vial format and supply chain infrastructure, the company is expanding its…
Read More
Facet Life Sciences Announces Partnership with Nucleus RadioPharma as Official Regulatory Partner
Facet is pleased to announce the company's role as the official regulatory partner of Nucleus RadioPharma, a leader in the field of diagnostic and therapeutic radiopharmaceuticals. As a partner of…
Read More
Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves
Charles Conroy, CEO of Nucleus RadioPharma, sat down with Onyx for a feature-length interview as part of the 36 CEOs to Watch in 2025 series published in Fortune.
Read More
Clarity and Nucleus RadioPharma sign Master Services Agreement and Cu-67 SAR-bisPSMA Clinical Supply Agreement
Nucleus RadioPharma has entered into a new agreement that will utilize their state-of-the-art facility located in Rochester, MN, to manufacture the 67Cu-SAR-bisPSMA drug product...
Read More
AstraZeneca-backed CDMO Nucleus RadioPharma to boost commercial capacity
As the radiopharma space heats up, CDMO Nucleus RadioPharma is expanding its commercial manufacturing with two new facilities to cater to potential clients outside North America. The CDMO has started…
Read More
Nucleus RadioPharma Expands Radiopharmaceutical Research, Development and Manufacturing Capacity, Addressing Nationwide Supply Chain Constraints
Nucleus RadioPharma today announced the development of two new facilities totaling over 100,000 square feet in Mesa, Arizona and Springhouse, Pennsylvania. These first-of-a-kind facilities will house research, development, and commercial…
Read More
Expanding Radiopharmaceuticals for Cancer Treatment: Addressing Supply and Manufacturing Challenges – Charles Conroy
Dr. Oliver Sartor interviews Chuck Conroy about Nucleus RadioPharma’s role in radiopharmaceutical manufacturing and distribution. Mr. Conroy explains that Nucleus RadioPharma aims to support both small and large pharmaceutical companies…
Read More
Nucleus RadioPharma CEO Chuck Conroy featured In C&EN article: Investment grows in radiopharma manufacturing
The rising interest in developing radiopharmaceuticals as cancer treatments is sparking increased investment in manufacturing these therapies.
Read More
Nucleus RadioPharma Secures Series A Extension Funding with AstraZeneca Investment
Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the closing of a Series A extension round with new investor AstraZeneca (LSE/STO/Nasdaq:…
Read More
CDMO Nucleus RadioPharma links up with ARTBIO to help produce prostate cancer candidate for clinical trials
ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials
Nucleus RadioPharma Announces Appointment of Chris McDonald from Kite, a Gilead Company, to Board of Directors
Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177
Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth
Nucleus RadioPharma Appoints Industry Veteran Mark Przekop as Chief Operating Officer to Lead Supply Chain Strategy
Nucleus RadioPharma Secures $56 Million Series A Funding to Expand Production of Radiopharmaceutical Treatments for Cancer Patients
Vista has historically been known for its large buyouts, but the PE firm has been doing a string of smaller deals this year
Upcoming Events
EANM
October 4-8, 2025
Barcelona, Spain